NxStage Medical Inc (NXTM)

Healthcare Healthcare Services Healthcare Equipment & Supplies

Suivre

Cours de l'action
Code mnémonique : NXTM Marché : NSM


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette Résultats financiers
Résultats financiers
 
Value bought

90 derniers jours

 
Value sold

90 derniers jours

 
Net insiders buying

90 derniers jours

 
Trades (buy and sell)

90 derniers jours

Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur Détails
2018-02-22 2018-02-20 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -26.4%
24,48
85 680 USD 		3 500 -26.4% 24,48 85 680 USD
2018-01-19 2018-01-16 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -25.4%
24,88
87 080 USD 		3 500 -25.4% 24,88 87 080 USD
2017-12-21 2017-12-20 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -24.5%
25,35
88 725 USD 		3 500 -24.5% 25,35 88 725 USD
2017-11-15 2017-11-15 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -23.7%
25,73
90 055 USD 		3 500 -23.7% 25,73 90 055 USD
2017-10-23 2017-10-20 VP Vente planifiée

TOWSE MATTHEW W

SVP and Chief Financial Office
4 030 -14.2%
27,50
110 825 USD 		4 030 -14.2% 27,50 110 825 USD
2017-10-23 2017-10-20 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -22.9%
27,50
96 250 USD 		3 500 -22.9% 27,50 96 250 USD
2017-10-04 2017-10-04 VP Vente planifiée

Turk Joseph E Jr

President
1 000 -1.4%
27,56
27 560 USD 		1 000 -1.4% 27,56 27 560 USD
2017-09-21 2017-09-20 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -22.2%
27,27
95 445 USD 		3 500 -22.2% 27,27 95 445 USD
2017-09-21 2017-09-20 VP Vente planifiée

TOWSE MATTHEW W

SVP and Chief Financial Office
4 300 -15.0%
27,27
117 261 USD 		4 300 -15.0% 27,27 117 261 USD
2017-09-05 2017-09-05 VP Vente planifiée

Turk Joseph E Jr

President
1 000 -1.3%
27,95
27 950 USD 		1 000 -1.3% 27,95 27 950 USD
2017-08-23 2017-08-21 VP Vente planifiée

TOWSE MATTHEW W

SVP and Chief Financial Office
4 300 -15.0%
29,22
125 646 USD 		4 300 -15.0% 29,22 125 646 USD
2017-08-15 2017-08-15 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -21.5%
29,21
102 235 USD 		3 500 -21.5% 29,21 102 235 USD
2017-08-10 2017-08-10 VP Vente planifiée

Turk Joseph E Jr

President
1 000 -1.3%
29,26
29 260 USD 		1 000 -1.3% 29,26 29 260 USD
2017-08-08 2017-08-07 VP Vente planifiée

Turk Joseph E Jr

President
18 000 -19.2%
29,63
533 340 USD 		18 000 -19.2% 29,63 533 340 USD
2017-08-08 2017-08-07 VP Vente planifiée

Turk Joseph E Jr

President
6 000 -6.0%
29,66
177 960 USD 		6 000 -6.0% 29,66 177 960 USD
2017-08-04 2017-08-03 VP Vente planifiée

Turk Joseph E Jr

President
7 000 -8.4%
22,98
160 860 USD 		7 000 -8.4% 22,98 160 860 USD
2017-07-21 2017-07-20 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -20.9%
24,16
84 560 USD 		3 500 -20.9% 24,16 84 560 USD
2017-07-21 2017-07-20 VP Vente planifiée

TOWSE MATTHEW W

SVP and Chief Financial Office
4 300 -15.0%
24,16
103 888 USD 		4 300 -15.0% 24,16 103 888 USD
2017-07-07 2017-07-05 VP Vente planifiée

Turk Joseph E Jr

President
1 000 -1.3%
25,19
25 190 USD 		1 000 -1.3% 25,19 25 190 USD
2017-06-21 2017-06-20 VP Vente planifiée

TOWSE MATTHEW W

SVP and Chief Financial Office
4 300 -14.5%
23,29
100 147 USD 		4 300 -14.5% 23,29 100 147 USD
2017-06-16 2017-06-15 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -20.3%
23,14
80 990 USD 		3 500 -20.3% 23,14 80 990 USD
2017-07-07 2017-06-14 VP Vente planifiée

Turk Joseph E Jr

President
1 000 -1.3%
23,74
23 740 USD 		1 000 -1.3% 23,74 23 740 USD
2017-06-12 2017-06-08 VP Vente planifiée

Turk Joseph E Jr

President
2 250 -2.8%
23,59
53 078 USD 		2 250 -2.8% 23,59 53 078 USD
2017-05-23 2017-05-22 VP Vente planifiée

TOWSE MATTHEW W

SVP and Chief Financial Office
4 300 -14.5%
21,36
91 848 USD 		4 300 -14.5% 21,36 91 848 USD
2017-05-15 2017-05-15 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -19.7%
21,94
76 790 USD 		3 500 -19.7% 21,94 76 790 USD
2017-05-11 2017-05-10 VP Vente planifiée

Turk Joseph E Jr

President
250 -0.3%
23,59
5 898 USD 		250 -0.3% 23,59 5 898 USD
2017-05-04 2017-05-03 VP Vente planifiée

Turk Joseph E Jr

President
1 000 -1.3%
29,95
29 950 USD 		1 000 -1.3% 29,95 29 950 USD
2017-04-21 2017-04-20 VP Vente planifiée

Burbank Jeffrey H

Chief Executive Officer
3 000 -0.3%
27,28
81 840 USD 		3 000 -0.3% 27,28 81 840 USD
2017-04-20 2017-04-20 VP Vente planifiée

TOWSE MATTHEW W

SVP and Chief Financial Office
4 300 -14.5%
27,28
117 304 USD 		4 300 -14.5% 27,28 117 304 USD
2017-04-20 2017-04-20 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -19.2%
27,28
95 480 USD 		3 500 -19.2% 27,28 95 480 USD
2017-04-20 2017-04-19 VP Vente planifiée

Burbank Jeffrey H

Chief Executive Officer
3 000 -0.3%
26,65
79 950 USD 		3 000 -0.3% 26,65 79 950 USD
2017-04-14 2017-04-13 VP Vente planifiée

Turk Joseph E Jr

President
1 000 -1.3%
26,10
26 100 USD 		1 000 -1.3% 26,10 26 100 USD
2017-04-04 2017-04-03 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
14 397 -51.4%
26,60
382 960 USD 		14 397 -51.4% 26,60 382 960 USD
2017-03-23 2017-03-22 VP Vente planifiée

Burbank Jeffrey H

Chief Executive Officer
3 000 -0.3%
27,42
82 260 USD 		3 000 -0.3% 27,42 82 260 USD
2017-03-22 2017-03-21 VP Vente planifiée

Burbank Jeffrey H

Chief Executive Officer
3 000 -0.3%
27,72
83 160 USD 		3 000 -0.3% 27,72 83 160 USD
2017-03-22 2017-03-20 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
15 723 -50.7%
27,66
434 898 USD 		15 723 -50.7% 27,66 434 898 USD
2017-03-22 2017-03-20 VP Vente planifiée

TOWSE MATTHEW W

SVP and Chief Financial Office
4 300 -14.5%
27,66
118 938 USD 		4 300 -14.5% 27,66 118 938 USD
2017-03-16 2017-03-16 V Vente

MOORE CRAIG W

1 000 -1.0%
27,93
27 930 USD 		1 000 -1.0% 27,93 27 930 USD
2017-03-08 2017-03-08 VP Vente planifiée

Turk Joseph E Jr

President
1 000 -1.2%
27,53
27 530 USD 		1 000 -1.2% 27,53 27 530 USD
2017-03-07 2017-03-07 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
20 000 -55.4%
27,75
555 000 USD 		20 000 -55.4% 27,75 555 000 USD
2017-03-06 2017-03-06 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
6 390 -28.4%
28,01
178 984 USD 		6 390 -28.4% 28,01 178 984 USD
2017-02-24 2017-02-23 VP Vente planifiée

Burbank Jeffrey H

Chief Executive Officer
7 500 -0.8%
28,97
217 275 USD 		7 500 -0.8% 28,97 217 275 USD
2017-02-23 2017-02-22 VP Vente planifiée

Burbank Jeffrey H

Chief Executive Officer
7 500 -0.8%
29,01
217 575 USD 		7 500 -0.8% 29,01 217 575 USD
2017-02-23 2017-02-21 VP Vente planifiée

TOWSE MATTHEW W

SVP and Chief Financial Office
4 300 -18.7%
29,26
125 818 USD 		4 300 -18.7% 29,26 125 818 USD
2017-02-21 2017-02-17 VP Vente planifiée

Turk Joseph E Jr

President
6 000 -8.0%
29,66
177 960 USD 		6 000 -8.0% 29,66 177 960 USD
2017-02-15 2017-02-15 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
16 049 -60.5%
28,01
449 532 USD 		16 049 -60.5% 28,01 449 532 USD
2017-02-15 2017-02-14 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
2 448 -12.4%
28,28
69 229 USD 		2 448 -12.4% 28,28 69 229 USD
2017-02-13 2017-02-10 VP Vente planifiée

Turk Joseph E Jr

President
2 500 -3.5%
28,59
71 475 USD 		2 500 -3.5% 28,59 71 475 USD
2017-02-13 2017-02-09 VP Vente planifiée

Turk Joseph E Jr

President
1 000 -1.4%
27,77
27 770 USD 		1 000 -1.4% 27,77 27 770 USD
2017-02-08 2017-02-08 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
3 054 -13.4%
27,61
84 321 USD 		3 054 -13.4% 27,61 84 321 USD
2017-02-07 2017-02-07 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
3 117 -12.0%
27,54
85 842 USD 		3 117 -12.0% 27,54 85 842 USD
2017-02-06 2017-02-06 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
3 283 -11.2%
27,29
89 593 USD 		3 283 -11.2% 27,29 89 593 USD
2017-02-06 2017-02-03 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
13 000 -30.8%
26,77
348 010 USD 		13 000 -30.8% 26,77 348 010 USD
2017-02-02 2017-02-02 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
17 745 -37.8%
26,72
474 146 USD 		17 745 -37.8% 26,72 474 146 USD
2017-02-02 2017-02-02 VP Vente planifiée

Turk Joseph E Jr

President
15 669 -18.2%
26,19
410 371 USD 		15 669 -18.2% 26,19 410 371 USD
2017-02-02 2017-02-01 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
19 602 -36.6%
26,65
522 393 USD 		19 602 -36.6% 26,65 522 393 USD
2017-01-26 2017-01-26 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
7 000 -14.7%
26,25
183 750 USD 		7 000 -14.7% 26,25 183 750 USD
2017-01-26 2017-01-25 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
20 000 -33.0%
26,13
522 600 USD 		20 000 -33.0% 26,13 522 600 USD
2017-01-26 2017-01-24 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
15 000 -27.0%
25,86
387 900 USD 		15 000 -27.0% 25,86 387 900 USD
2017-01-23 2017-01-23 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
15 000 -27.0%
25,74
386 100 USD 		15 000 -27.0% 25,74 386 100 USD
2017-01-23 2017-01-20 VP Vente planifiée

Swan Winifred L

SVP and General Counsel
3 500 -24.2%
26,19
91 665 USD 		3 500 -24.2% 26,19 91 665 USD
2017-01-23 2017-01-20 VP Vente planifiée

TOWSE MATTHEW W

SVP and Chief Financial Office
4 300 -18.7%
26,19
112 617 USD 		4 300 -18.7% 26,19 112 617 USD
2017-01-23 2017-01-19 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
200 -0.5%
27,91
5 582 USD 		200 -0.5% 27,91 5 582 USD
2017-01-23 2017-01-19 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
6 415 -13.6%
27,23
174 680 USD 		6 415 -13.6% 27,23 174 680 USD
2017-01-18 2017-01-18 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
8 183 -14.8%
27,58
225 687 USD 		8 183 -14.8% 27,58 225 687 USD
2017-01-18 2017-01-18 VP Vente planifiée

Burbank Jeffrey H

Chief Executive Officer
7 500 -0.9%
27,63
207 225 USD 		7 500 -0.9% 27,63 207 225 USD
2017-01-17 2017-01-17 VP Vente planifiée

Brown Robert S.

President, NxStage Kidney Care
10 805 -16.3%
27,72
299 515 USD 		10 805 -16.3% 27,72 299 515 USD
2017-01-17 2017-01-17 VP Vente planifiée

Burbank Jeffrey H

Chief Executive Officer
7 500 -0.8%
27,52
206 400 USD 		7 500 -0.8% 27,52 206 400 USD
2017-01-17 2017-01-13 VP Vente planifiée

Turk Joseph E Jr

President
7 500 -9.6%
28,00
210 000 USD 		7 500 -9.6% 28,00 210 000 USD
2017-01-11 2017-01-11 VP Vente planifiée

Turk Joseph E Jr

President
1 000 -1.3%
27,77
27 770 USD 		1 000 -1.3% 27,77 27 770 USD
2016-12-20 2016-12-20 VP Vente planifiée

TOWSE MATTHEW W

SVP and Chief Financial Office

Dirigeant
4 300 -18.7%
25,55
109 865 USD 		4 300 -18.7% 25,55 109 865 USD
2016-12-16 2016-12-15 VP Vente planifiée

Swan Winifred L

SVP and General Counsel

Dirigeant
3 500 -23.4%
25,91
90 685 USD 		3 500 -23.4% 25,91 90 685 USD
2016-12-14 2016-12-14 VP Vente planifiée

Burbank Jeffrey H

Chief Executive Officer

Administrateur exécutif
7 500 -0.8%
25,68
192 600 USD 		7 500 -0.8% 25,68 192 600 USD
2016-12-13 2016-12-13 VP Vente planifiée

Turk Joseph E Jr

President

Dirigeant
1 000 -1.3%
25,42
25 420 USD 		1 000 -1.3% 25,42 25 420 USD
2016-12-13 2016-12-13 VP Vente planifiée

Burbank Jeffrey H

Chief Executive Officer

Administrateur exécutif
7 500 -0.8%
25,42
190 650 USD 		7 500 -0.8% 25,42 190 650 USD
// ... existing code ... // ... rest of the file ...